Cargando…

Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome

OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Krueger, Marcus, Heinzmann, Andrea, Nauck, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095409/
https://www.ncbi.nlm.nih.gov/pubmed/17124613
http://dx.doi.org/10.1007/s00134-006-0453-6
_version_ 1783510664305704960
author Krueger, Marcus
Heinzmann, Andrea
Nauck, Markus
author_facet Krueger, Marcus
Heinzmann, Andrea
Nauck, Markus
author_sort Krueger, Marcus
collection PubMed
description OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) with or without infection-triggered organ failure. DESIGN AND SETTING: Prospective pilot study, a level III neonatal and pediatric intensive care unit at a University children's Hospital. PATIENTS: We studied 22 ventilated pediatric (n = 15) and neonatal (n = 7) intensive care patients (aged 3 days–16 years). Inclusion criteria were mechanical ventilation and signs of at least one additional organ dysfunction (cardiovascular, respiratory, neurological, hematological, or renal). MEASUREMENTS AND RESULTS: Serum concentrations of the adhesion molecules were analyzed on the day of maximum organ dysfunction score and were quantitated by a sandwich ELISA technique. The overall mortality rate was 36% (8/22). Dysfunction of three or more organ systems was defined as MODS and was associated with a significant increase in VCAM-1 serum levels relative to dysfunction of three or fewer organ systems [median 1239 ng/ml (IQR 928–1615) vs. 766 ng/ml (644–915)]. A significant difference in E-selectin serum levels was found between organ failure of infectious (median 131 ng/ml, IQR 112–146) and noninfectious origin (68 ng/ml 49–105). CONCLUSIONS: Determination of adhesion molecules in pediatric intensive care patients raises the possibility of more specific pathophysiological understanding. E-selectin showed significantly different serum levels between infectious and noninfectious causes of organ failure.
format Online
Article
Text
id pubmed-7095409
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70954092020-03-26 Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome Krueger, Marcus Heinzmann, Andrea Nauck, Markus Intensive Care Med Pediatric Brief Report OBJECTIVE: To determine serum concentrations of the soluble forms of vascular cell adhesion molecule 1 (VCAM-1), intracellular adhesion molecule 1 (ICAM-1), and E-selectin in ventilated neonatal and pediatric intensive care patients with varying severity of multiorgan dysfunction syndrome (MODS) with or without infection-triggered organ failure. DESIGN AND SETTING: Prospective pilot study, a level III neonatal and pediatric intensive care unit at a University children's Hospital. PATIENTS: We studied 22 ventilated pediatric (n = 15) and neonatal (n = 7) intensive care patients (aged 3 days–16 years). Inclusion criteria were mechanical ventilation and signs of at least one additional organ dysfunction (cardiovascular, respiratory, neurological, hematological, or renal). MEASUREMENTS AND RESULTS: Serum concentrations of the adhesion molecules were analyzed on the day of maximum organ dysfunction score and were quantitated by a sandwich ELISA technique. The overall mortality rate was 36% (8/22). Dysfunction of three or more organ systems was defined as MODS and was associated with a significant increase in VCAM-1 serum levels relative to dysfunction of three or fewer organ systems [median 1239 ng/ml (IQR 928–1615) vs. 766 ng/ml (644–915)]. A significant difference in E-selectin serum levels was found between organ failure of infectious (median 131 ng/ml, IQR 112–146) and noninfectious origin (68 ng/ml 49–105). CONCLUSIONS: Determination of adhesion molecules in pediatric intensive care patients raises the possibility of more specific pathophysiological understanding. E-selectin showed significantly different serum levels between infectious and noninfectious causes of organ failure. Springer-Verlag 2006-11-24 2007 /pmc/articles/PMC7095409/ /pubmed/17124613 http://dx.doi.org/10.1007/s00134-006-0453-6 Text en © Springer-Verlag 2006 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Pediatric Brief Report
Krueger, Marcus
Heinzmann, Andrea
Nauck, Markus
Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title_full Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title_fullStr Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title_full_unstemmed Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title_short Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
title_sort adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome
topic Pediatric Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095409/
https://www.ncbi.nlm.nih.gov/pubmed/17124613
http://dx.doi.org/10.1007/s00134-006-0453-6
work_keys_str_mv AT kruegermarcus adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome
AT heinzmannandrea adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome
AT nauckmarkus adhesionmoleculesinpediatricintensivecarepatientswithorgandysfunctionsyndrome